Carnitine palmitoyltransferase in patients with cardiac ischemia due to atherosclerotic coronary artery disease and in patients with idiopathic dilated cardiomyopathy

Cardiology (Switzerland)

Volumn 88, Issue 3, 1997, Pages 258-263

  Maurer, Iris ^a   Zierz, Stephan ^b  

^a UNIVERSITY OF BONN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Carnitine palmitoyltransferase; Coronary artery disease; Dilated cardiomyopathy; Mitochondria

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; MALONYL COENZYME A; TRITON X 100;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME ACTIVITY; FATTY ACID METABOLISM; HEART DILATATION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0030905471     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177340     Document Type: Article

References (31)

1. Opic LH. Owen P. Riemersma RA: Relative rates of oxidation of glucose and free fatty acids by ischaemic and non-ischaemic myocardium after coronary artery ligation in the dog. Eur J Clin Invest 1973:3:419-435.
2. Schwaiger M, Schclbcrt HR, Ellison D. Hansen H. Yeatman L, Vinten-Johansen J, Selin C, Barrio J. Phelps ME: Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985:6:336-347.
3. Van der Vussc GJ. Rocmen THM. Prinzen FW. Coumans WA. Reneman RS: Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions. C’irc Res 1982:50:538-546.
4. Van Bilsen M. van der Vussc GJ, Willemsen PHM, Coumans WA, Reneman RS: Fatty acid accumulation during ischemia and reperfusion: Effects of pyruvate and POCA. A carnitine palmitoyltransferase I inhibitor. J Mol Cell Cardiol 1991;23:143-144.
5. Challoner D. Steinberg D: Metabolic effect of epinephrine on the QOj of the arrested isolated perfused rat heart. Nature 1965:205:602-603.
6. Idell-Wcngcr JA, Grotvohann LW. Neely JR: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 1978; 253:4310-4318.
7. Laniers JMJ. de Jonge-Stinis JT. Verdomv PD. Hiilsmann WC: On the possible role of long chain fatty acylcamitinc accumulation in producing functional and calcium permeability changes in membranes during myocardial ischemia. Cardiovasc Res 1987;21:313-322.
8. Van der Vusse GJ. Glatz JFC. Slam HCG. Reneman RS: Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 1992:72:881-940.
9. Abe M, Yamazaki N. Suzuki Y. Kobayashi A. Ohta H: Effect of palmitoylcarnitine on Na.K-ATPase and adenylate cyclase activity of canine myocardial sarcolemma. J Mol Cell Cardiol 1984:16:239-245.
10. Pitts BJR, Tate CA. van Winkle B. Wood JM. Entman ML: Palmitoylcarnitine inhibition of the calcium pump in cardiac sarcoplasmic reticulum: A possible role in myocardial ischemia. Life Sci 1978:23:391-402.
11. Schwartz A, Wood JM. Allen JC. Bomet EP. Entman ML, Goldstein MA. Sordahl LA. Suzuki M: Biochemical and morphologic correlates of cardiac ischemia. I. Membrane systems. Am J Cardiol 1973:32:46-61.
12. Bieber LL: Carnitine. Annu Rev Biochcm 1988:57:261-283.
13. McMillin Wood J. Sordahl LA. Lewis RM. Schwartz A: Effect of chronic myocardial ischemia on the activity of carnitine palmitoyl-cocnzymc A transferase of isolated canine heart mitochondria. Cire Res 1973:32:340-347.
14. Bielefeld DR, Vary TC. Neely JR: Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfeni-cine in cardiac muscle. J Mol Cell Cardiol 1985:17:619-625.
15. Bcyncn AC. Buechler KF. van der Molen AJ. Geclen MJ H: The effects of lactate and acetate on fatty acid and cholesterol biosynthesis by isolated rat hépatocytes. Int J Biochcm 1982: 14:165-169.
16. Saggcrson ED. Carpenter CA: Carnitine palmitoyltransferase and carnitine octanoyltransfer-asc activities in liver, kidney cortex, adipocyte, lactating mammary gland, skeletal muscle and heart. Relative activities, latency and effect of malonyl-CoA. FEBS Lett 1981:129:229-232.
17. McGarry JD. Mills SE. Long CS, Foster DW: Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochcm J 1983:214:21-28.
18. Pauly DF, Kirk KA. McMillan JB: Carnitine palmitoyltransferase in cardiac ischemia. A potential site for altered fatty acid metabolism. CircRcs 1991.68:1085-1094.
19. Licdtke AJ, Renstrom B. Nellis SL, Subraman-ian R, Woldegiorgis G: Myocardial metabolism in chronic reperfusion after nontransmural infarction in pig hearts. Am J Physiol 1993:265: H1614-HI622.
20. Zicrz S. Engel AG: Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochcm 1985; 149: 207-214.
21. Pauly DF, Yoon SB. McMillin JB: Carnitinc-acylcamitine translocasc in ischemia: Evidence for sulfhydryl modification. Am J Physiol 1987,253:H1557-H1565.
22. Simkhovich BZ. Hale SL. Ovizc M. Przyklcnk K. Kloner RA: Ischemic preconditioning and long-chain acylcarnitine in the canine heart. Coron Artery Dis 1993:4:387-392.
23. Wocltje K, Esser V. Weis BC. Cox WF. Schroeder JG. Liao ST. Foster DW. McGarry JD: Inter-tissue and inter-species characteristics of the mitochondrial carnitine palmitoyltransferase enzyme system. J Biol Chcm 1990: 265:10714-10719.
24. Saggerson F.D, Carpenter CA: Effects of fasting, adrenalectomy and slreptozotocin diabetes in sensitivity of hepatic carnitine acyltransfcr-ase to malonyl-CoA. FEBS Lett 1981:129:225-228.
25. Bird W.I. Saggerson ED: Binding of malonyl-CoA to isolated mitochondria. Evidence for high-and low-affinity sites in liver and heart and relationship to inhibition of carnitine palmitoyltransferase activity. Biochcm J 1984: 222:639-647.
26. Cook GA: Differences in the sensitivity of carnitine palmitoyltransferase to inhibition by malonyl-CoA arc due to differences in K, J Biol Chem 1984;259:12030-12033.
27. Gamble MS. Cook GA: Alteration of the apparent K of carnitine palmitoyltransferase for ma-lonyl-CoA by the diabetic state and reversal by insulin. J Biol Chem 1985:260:9516-9519.
28. Bremer J:The Heel off as lingon the activity of liver carnitine palmitoyltransferase and its inhibition by malonyl-CoA. Biochim Biophys Acta 1981:665:628-631.
29. Mynatt RL. Lappi MD. Cook GA: Myocardial carnitine palmitoyltransferase of the mitochondrial outer membrane is not altered by fasting. Biochim Biophys Acta 1992:1128:105-111.
30. Zierz S. Neumann-Schmidt S. Jersualem F: Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long-chain acylcarnitine and acyl-coenzymc A. Clin Investig 1993:71:763-769.
31. Zicrz S. Engel AG. Olek K: The Seri l3Leu mutation in the carnitine palmitoyltransferase II gene in patients with muscle carnitine palmitoyltransferase deficiency. Muscle Nerve 1994: suppl LSI29.